- Revolutionising cancer treatment, using complex data integration
- Accelerating cure through innovation and precision medicine
- Excelling by combining global partnerships with Cambridge
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by re-inventing the treatment pathway for patients.
You can find a full list of media coverage about MFICM on the News page
Dr Jean Abraham will discuss how we combine cutting edge research of various types of breast cancer with clinical trials, to deliver more precise treatment for individual patients in this webinar.
MFICM co-authored article in Insights Into Imaging, 17 Aug 2020.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
